The $12 billion athletic-wear maker needs to put the focus back on performance rather than share classes, says Breakingviews.
The former acting Attorney General comes from a long line of groundbreaking Southern lawyers.
Here's the problem with Peter Thiel's 'Yelp for drugs' approach to the FDA, writes Vox's Julia Belluz.
Elon Musk has hinted he is working on an AI-based 'neural lace,' but what is it?
Liz Ann Sonders would like to see the White House get back to talking about fiscal stimulus, taxes and regulations.
Currency watchers say they are not ready to change their outlook on the greenback just because of rhetoric from the White House.
Millionaires are seen passing down as much as $30 trillion. But a study suggests neither the wealthy nor their kids are ready.
Despite their steep tuition tabs, these private schools are bringing costs way down with generous financial aid packages.
Gen. Keith Alexander, former National Security Agency director, speaks to CNBC's Eamon Javers about President Trump's cybersecurity meeting.
The self-made billionaire has learned a lot working with brilliant leaders and entrepreneurs.
As President Trump and Congress haggle over infrastructure repair, American motorists dodging potholes are already shelling out billions.
Kelly has faced a tough task in enforcing an order that he reportedly knew little about before it was signed.
These employers are providing the most opportunities for flexibility.
The Diageo-owned brand will be creating a version of its Dublin-based Guinness Open Gate Brewery in Relay, Maryland.
Aetna Chief Mark Bertolini also said the insurer is weighing its options after a judge blocked its proposed $37 billion merger with Humana.
At least a few people have told Elon Musk they are canceling orders for the yet-to-be-released Model 3 over Musk's collaboration Trump.
The notion that Trump's campaign talk was 'political bluster' is crumbling, the New York Times reports.
In Februaries following election years, the S&P 500 slides by an average of nearly 2 percent.
A closely watched gauge of what's happening with worker salaries showed only muted progress as 2016 came to a close.
"We have to get the prices down," Trump tells drugmakers at the White House.